PL1765303T5 - Tabletka doustna zabezpieczona przed nadużywaniem - Google Patents

Tabletka doustna zabezpieczona przed nadużywaniem

Info

Publication number
PL1765303T5
PL1765303T5 PL05769988.6T PL05769988T PL1765303T5 PL 1765303 T5 PL1765303 T5 PL 1765303T5 PL 05769988 T PL05769988 T PL 05769988T PL 1765303 T5 PL1765303 T5 PL 1765303T5
Authority
PL
Poland
Prior art keywords
dosage form
oral dosage
safeguarded against
against abuse
form safeguarded
Prior art date
Application number
PL05769988.6T
Other languages
English (en)
Other versions
PL1765303T3 (pl
Inventor
Johannes Bartholomäus
Heinrich Kugelmann
Elisabeth Arkenau-Maric
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35062975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1765303(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004032049A external-priority patent/DE102004032049A1/de
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of PL1765303T3 publication Critical patent/PL1765303T3/pl
Publication of PL1765303T5 publication Critical patent/PL1765303T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
PL05769988.6T 2004-07-01 2005-06-29 Tabletka doustna zabezpieczona przed nadużywaniem PL1765303T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102004032049A DE102004032049A1 (de) 2004-07-01 2004-07-01 Gegen Missbrauch gesicherte, orale Darreichungsform
US10/890,763 US20060002860A1 (en) 2004-07-01 2004-07-14 Abuse-proofed oral dosage form
EP05769988.6A EP1765303B2 (de) 2004-07-01 2005-06-29 Gegen missbrauch gesicherte, oral tablette
PCT/EP2005/006984 WO2006002884A1 (de) 2004-07-01 2005-06-29 Gegen missbrauch gesicherte, orale darreichtungsform

Publications (2)

Publication Number Publication Date
PL1765303T3 PL1765303T3 (pl) 2013-05-31
PL1765303T5 true PL1765303T5 (pl) 2023-05-22

Family

ID=35062975

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05769988.6T PL1765303T5 (pl) 2004-07-01 2005-06-29 Tabletka doustna zabezpieczona przed nadużywaniem

Country Status (8)

Country Link
EP (1) EP1765303B2 (pl)
JP (1) JP5259183B2 (pl)
AR (1) AR049562A1 (pl)
AU (1) AU2005259476B2 (pl)
CA (1) CA2572491A1 (pl)
FI (1) FI1765303T4 (pl)
PL (1) PL1765303T5 (pl)
WO (1) WO2006002884A1 (pl)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2957281A1 (en) 2001-09-21 2015-12-23 Egalet Ltd. Polymer release system
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
ES2360102T3 (es) 2003-03-26 2011-05-31 Egalet A/S Sistema para la liberación controlada de morfina.
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102004052515B4 (de) 2004-10-22 2019-01-03 Aesculap Ag Chirurgische Schere und Verfahren zum Herstellen einer chirurgischen Schere
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
EP1991207A2 (en) * 2006-01-21 2008-11-19 Abbott GmbH & Co. KG Dosage form and method for the delivery of drugs of abuse
FR2898056B1 (fr) * 2006-03-01 2012-01-20 Ethypharm Sa Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
DE102006051020A1 (de) * 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
DE102007022790A1 (de) * 2007-05-11 2008-11-20 Grünenthal GmbH Axomadol zur Schmerzbehandlung bei Arthrose
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
MX2010008138A (es) 2008-01-25 2010-08-10 Gruenenthal Gmbh Forma de dosis farmaceutica.
RU2508092C2 (ru) 2008-05-09 2014-02-27 Грюненталь Гмбх Способ получения твердой лекарственной формы, в частности таблетки для фармацевтического применения, и способ получения прекурсора твердой лекарственной формы, в частности таблетки
EP2393484A1 (en) 2009-02-06 2011-12-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
WO2011009604A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
AR077493A1 (es) 2009-07-22 2011-08-31 Gruenenthal Gmbh Composicion farmaceutica extruida en caliente con liberacion controlada. procedimiento de preparacion
CA2784407A1 (en) 2009-12-17 2011-07-14 Cima Labs Inc. Abuse-resistant formulations
CN102821757B (zh) 2010-02-03 2016-01-20 格吕伦塔尔有限公司 通过挤出机制备粉末状药物组合物
AR082862A1 (es) * 2010-09-02 2013-01-16 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico
WO2012028319A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
EP2611428B1 (en) 2010-09-02 2015-01-14 Grünenthal GmbH Tamper resistant dosage form comprising an anionic polymer
ME02874B (me) 2010-12-22 2018-04-20 Purdue Pharma Lp Obloženi dozni oblici sa kontrolisanim oslobađanjem otporni na zloupotrebu
AU2011346758C1 (en) 2010-12-23 2015-09-03 Purdue Pharma L.P. Tamper resistant solid oral dosage forms
PL2688556T3 (pl) * 2011-03-25 2015-10-30 Purdue Pharma Lp Postaci dawkowania o kontrolowanym uwalnianiu
NO2736497T3 (pl) 2011-07-29 2018-01-20
KR20140053159A (ko) 2011-07-29 2014-05-07 그뤼넨탈 게엠베하 즉시 약물 방출을 제공하는 탬퍼-저항성 정제
BR112014008120A2 (pt) * 2011-10-06 2017-04-11 Gruenenthal Gmbh forma inviolável de dosagem farmacêutica oral compreendendo agonista de opioide e antagonista de opioide
JP6085307B2 (ja) 2011-11-17 2017-02-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な成分、オピオイドアンタゴニストおよび／または嫌忌剤（ａｖｅｒｓｉｖｅａｇｅｎｔ）、ポリアルキレンオキシドおよび陰イオン性ポリマーを含むタンパーレジスタント経口医薬剤形
US20130225625A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
WO2013127831A1 (en) 2012-02-28 2013-09-06 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
PT2838512T (pt) 2012-04-18 2018-11-09 Gruenenthal Gmbh Forma farmacêutica resistente à adulteração e resistente à libertação inesperada de alta quantidade (dose-dumping)
JP2015516406A (ja) 2012-05-11 2015-06-11 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 亜鉛を含む熱成形された不正使用防止医薬剤形
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9549899B2 (en) 2012-07-06 2017-01-24 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
BR112015017451B1 (pt) 2013-02-05 2023-01-10 Purdue Pharma L.P. Formulações farmacêuticas resistentes à violação
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
AR096439A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido que contiene una o más partículas
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
KR20160031526A (ko) * 2013-07-12 2016-03-22 그뤼넨탈 게엠베하 에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형
CN105934241B (zh) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 通过低温研磨制备粉末状药物组合物
JP2016540798A (ja) 2013-12-16 2016-12-28 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形
EP3082775A4 (en) * 2013-12-17 2017-05-17 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
WO2016124530A1 (en) 2015-02-03 2016-08-11 Grünenthal GmbH Tamper-resistant dosage form comprising a polyethylene glycol graft copolymer
EP3285745A1 (en) 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
CA2983634A1 (en) 2015-04-24 2016-10-27 Grunenthal Gmbh Tamper-resistant fixed dose combination providing fast release of two drugs from particles
US20160310428A1 (en) 2015-04-24 2016-10-27 Grunenthal Gmbh Tamper-resistant fixed dose combination providing fast release of two drugs from different particles
WO2016170093A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
US20170296476A1 (en) 2016-04-15 2017-10-19 Grünenthal GmbH Modified release abuse deterrent dosage forms
CA3029869A1 (en) 2016-07-06 2018-01-11 Grunenthal Gmbh Reinforced pharmaceutical dosage form
CA3032598A1 (en) 2016-08-01 2018-02-08 Grunenthal Gmbh Tamper resistant dosage form comprising an anionic polysaccharide
AU2017310006A1 (en) 2016-08-12 2019-01-31 Grünenthal GmbH Tamper resistant formulation of ephedrine and its derivatives
US20190110992A1 (en) 2017-10-13 2019-04-18 Grünenthal GmbH Modified release abuse deterrent dosage forms
TW202002957A (zh) 2018-02-09 2020-01-16 德商歌林達有限公司 包含轉化抑制劑之麻黃素及其衍生物之抗損壞調配物
EP3698776A1 (en) 2019-02-19 2020-08-26 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
WO2021219577A1 (en) 2020-04-27 2021-11-04 Grünenthal GmbH Dosage form comprising hot-melt extruded pellets containing eva copolymer and gliding agent
WO2021219576A1 (en) 2020-04-27 2021-11-04 Grünenthal GmbH Multiparticulate dosage form containing eva copolymer and additional excipient
CN115702888A (zh) * 2021-08-13 2023-02-17 合肥立方制药股份有限公司 一种盐酸羟考酮渗透泵缓释片及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004601A (en) * 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
EP0914097B1 (en) * 1996-03-12 2002-01-16 Alza Corporation Composition and dosage form comprising opioid antagonist
PT1014941E (pt) † 1996-06-26 2009-07-08 Univ Texas Formulação farmacêutica extrudível por termofusão
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US7332182B2 (en) * 2001-08-06 2008-02-19 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
US7141250B2 (en) * 2001-08-06 2006-11-28 Euro-Celtique S.A. Pharmaceutical formulation containing bittering agent
US7144587B2 (en) * 2001-08-06 2006-12-05 Euro-Celtique S.A. Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
DE10250083A1 (de) * 2002-06-17 2003-12-24 Gruenenthal Gmbh Gegen Missbrauch gesicherte Darreichungsform
US7399488B2 (en) * 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
DE10250087A1 (de) * 2002-10-25 2004-05-06 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10250088A1 (de) * 2002-10-25 2004-05-06 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10250084A1 (de) * 2002-10-25 2004-05-06 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10336400A1 (de) * 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
KR20120104199A (ko) † 2003-08-06 2012-09-20 그뤼넨탈 게엠베하 남용 방지 제형
DE10361596A1 (de) * 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform

Also Published As

Publication number Publication date
AU2005259476B2 (en) 2010-07-29
WO2006002884B1 (de) 2006-03-02
JP5259183B2 (ja) 2013-08-07
CA2572491A1 (en) 2006-01-12
WO2006002884A1 (de) 2006-01-12
AU2005259476A1 (en) 2006-01-12
EP1765303A1 (de) 2007-03-28
AR049562A1 (es) 2006-08-16
PL1765303T3 (pl) 2013-05-31
JP2008504327A (ja) 2008-02-14
FI1765303T4 (fi) 2023-01-31
EP1765303B2 (de) 2022-11-23
EP1765303B1 (de) 2013-02-20

Similar Documents

Publication Publication Date Title
IL180470A0 (en) Oral dosage form safeguarded against abuse
PL1765303T3 (pl) Doustna postać dawkowania zabezpieczona przed nadużywaniem
IL251539A0 (en) Single pharmaceutical dosage form
HK1095081A1 (en) Dosage form that is safeguarded from abuse
IL173558A0 (en) Dosage form that is safeguarded from abuse
IL174343A0 (en) Delayed released dosage forms
ZA200700851B (en) Medicament dispenser
SG114683A1 (en) Medicament dispenser
GB0419849D0 (en) Pharmaceutical combination
GB0704141D0 (en) Topical medicament
IL184787A0 (en) Oral dosage form comprising rosiglitazone
IL184790A0 (en) Oral dosage form comprising rosiglitazone
HK1115808A1 (en) Analgesic
GB0427455D0 (en) Dosage forms
GB0423964D0 (en) Dosage form
IL180487A0 (en) Medicament
EP1753400A4 (en) PHARMACEUTICAL FOR ZIPRASIDONE
ZA200605666B (en) Solid dosage form
GB0512453D0 (en) Dosage unit
GB0402491D0 (en) Medicaments
GB0426942D0 (en) Medicament
GB0409098D0 (en) Medicament
GB0424994D0 (en) Dosage form
GB0411047D0 (en) Dosage form
GB0417777D0 (en) Pharmaceutical combination